Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
2006-08-29
2006-08-29
Schwadron, Ronald B. (Department: 1644)
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
C435S375000, C530S403000, C530S806000, C424S193100, C424S192100, C424S197110
Reexamination Certificate
active
07097965
ABSTRACT:
The present invention provides a vaccine for inducing an immune response in mammal to a specific antigen, where the vaccine comprises a unit dose of a binary toxin protective antigen and the antigen, which is bound to a binary toxin protective antigen binding protein. In one embodiment the vaccine is comprised of an anthrax protective antigen and the antigen bound to anthrax protective antigen binding protein. The present invention also provides a method of immunizing a mammal against an antigen using the vaccine, and a method of inducing antigen-presenting mammalian cells to present specific antigens via the MHC class I processing pathway.
REFERENCES:
patent: 5591631 (1997-01-01), Leppla
patent: 0532090 (1993-03-01), None
patent: WO 92/19720 (1992-11-01), None
patent: WO 94/18332 (1994-08-01), None
patent: WO 97/23236 (1997-07-01), None
Milne et al Molec. Microbiol. 15:661-666, 1992.
Radha, C., et al. (1996) “Thermostabilization of protective antigen—the binding component of anthrax lethal toxin”,Journal of Biotechnology50:235-242.
Ballard, Jimmy D., et al. (1996) “Anthrax toxin-mediated delivery of a cytotoxic T-cell epitopein vivo”, Proc. Natl Acad. Sci. USA, 93:12531-12534.
Sirard, Jean-Claude, et al. (1997) “A RecombinantBacillus anthracisStrain Producing theClostridium perfringensIb Component Induces Protection against Iota Toxins”,Infection and Immunity, 65(6):2029-2033.
Goletz, T.J., et al. (1997) “Delivery of Antigens to the MHC Class I Pathway Using Bacterial Toxins”,Human Immunology54:129-136.
Carbonetti, N., et al. (1995) “Use of Pertussis Toxin Vaccine Molecule PT9K/129G to Deliver Peptide Epitopes for Stimulation of a Cytotoxic T Lymphocyte Response”,Abstr. Annu. Meeting Amer. Soc. Microbiology95:295, No. E-86.
Carbonetti, N., et al. (1996) “Development of Pertussia and Cholera Toxins as Cytotoxic T Lymphocyte Vaccine Vector Molecules”,Abstr. Annu. Meeting Amer. Soc. Microbiology96, No. E-59.
Ballard, Jimmy D., et al. (1997) “Anthrax Toxin-Mediated Delivery of Listeria Specific CTL Epitopesin vivo”, Abstr. Annu. Meeting Amer. Soc. Microbiology97, No. B-99.
Doling, A.M., et al. (1997) “Anthrax Toxin as a Delivery System for Viral and Bacterial Cytotoxic T-Cell Eptitopes”,Abstr. Annu. Meeting Amer. Soc. Microbiology97, No. B-101.
Donnelly, John, J., et al. (1993) “Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modifiedPseudomonasexotoxin”,Proc. Natl. Acad. Sci. USA, 90:3530-3534.
Fayolle, Catherine, et al. (1996) “In Vivo Induction of CTL Responses by Recombinant Adenylate Cyclase ofBordetella pertussisCarrying Viral CD8+T Cell Epitopes”,Journal of Immunology4697-4706.
Madshus, Inger Helene, et al. (1991) “Entry of Diphtheria Toxin-Protein A Chimeras into Cells”,The Journal of Biological Chemistry, 266(26) :17446-17453.
Madshus, Inger Helene, et al. (1992) “Membrane Translocation of Diphtheria Toxin Carrying Passenger Protein Domains”,Infection and Immunity, 60(8) :3296-3302.
Perelle, Sylvie, et al. (1993) “Characterization ofClostridium perfringensIota-Toxin Genes and Expression inEscherichia coli”, Infection and Immunity61(12) :5147-5156.
Sebo, Peter, et al. (1995) “Cell-Invasive Activity of Epitope-Tagged Adenylate Cyclase ofBordetella pertussisAllows In Vitro Presentation of a Foreign Epitope to CD8+Cytotoxic T Cells”,Infection and Immunity, 63(10) :3851-3857.
Ulmer, Jeffrey B., et al. (1994) “Presentation of an exogenous antigen by major histocompability complex class I molecules”,Eur. J. Immunology, 24:1590-1596.
Arora, Naveen, et al. (1994) “Cytotoxic Effects of a Chimeric Protein Consisting of Tetanus Toxin Light Chain and Anthrax Toxin Lethal Factor in Non-Neuronal Cells”,The Journal of Biological Chemistry, 269 (42) :26165-26171.
Arora, Naveen, et al. (1994) “Fusions of Anthrax Toxin Lethal Factor with Shiga Toxin and Diphtheria Toxin Enzymatic Domains are Toxic to Mammalian Cells”,Infection and Immunity, 62 (11) :4955-4961.
Arora, Naveen, et al. (1993) “Residues 1-254 of Anthrax Toxin Lethal Factor Are Sufficient to Cause Cellular Uptake of Fused Polypeptides”,The Journal of Biological Chemistry268 (5) :3334-3341.
Singh, Yogendra, et al. (1991) “The Carboxyl-terminal End of Protective Antigen is Required for Receptor Binding and Anthrax Toxin Activity”,The Journal of Biological Chemistry, 266(23) :15493-15497.
Arora, Naveen, et al. (1992) “Fusions of Anthrax Toxin Lethal Factor to the ADP-Ribosylation Domain ofPseudomonasExotoxin A are Potent Cytotoxins which are Translocated to the Cytosol of Mammalian Cells”,The Journal of Biological Chemistry, 267(22) :15542-15548.
Arora Naveen
Berzofsky Jay A.
Goletz Theresa J.
Klimpel Kurt
Leppla Stephen H.
Schwadron Ronald B.
The United States of America as represented by the Department of
LandOfFree
Targeting antigens to the MHC class I processing pathway... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting antigens to the MHC class I processing pathway..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting antigens to the MHC class I processing pathway... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3635493